Growth in first year appears unaffected by prenatal SSRI use

03/20/2013 | HealthDay News

Taking selective serotonin reuptake inhibitors during pregnancy may not affect an infant's growth during the first year of life, according to a study published online in the American Journal of Psychiatry. Researchers found that babies born to mothers who took the antidepressants had comparable weight, length and head circumference as babies with no exposure to the drugs.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations